Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 287

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

History of Antibiotics Research

Mohr, Kathrin I.·2016·Current Topics in Microbiology and Immunology
DOI 10.1007/82_2016_499
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/82_2016_499

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 133

  1. Abraham EP, Chain E (1940) An enzyme from bacteria able to destroy penicillin. Nature 146:837 · DOI · Paper page
  2. Aminov RI (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 1:134 · DOI · Paper page
  3. Baltz RH (1998) Genetic manipulation of antibiotic producing Streptomyces. Trends Microbiol 2:76–83 · doi:10.1016/s0966-842x(97)01161-x
  4. Bange F-C, Fille M (2012) Antimykobakterielle therapie chapter 105. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7 Auflage Springer, Berlin · doi:10.1007/978-3-642-24167-3_105
  5. Bange F-C, Hahn H, Kaufmann SHE, Ulrichs T (2012) Mykobakterien. Chapter 41. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7 Auflage. Springer, Berlin
  6. Barber M (1961) Methicillin-resistant staphylococci. J Clin Pathol 14:385–393 · DOI · Paper page
  7. Béchamp MA (1863) De l’action de la chaleur sur l’arseniate d’analine et de la formation d’un anilide de l’acide arsenique. Compt Rend 56:1172–1175
  8. Bennett JW (2015) What is an antibiotic? In: Sánchez S, Demain AL (eds) Antibiotics-current innovations and future trends. Caister Academic Press · doi:10.21775/9781908230546.01
  9. Bentley R (2000) Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev 100:3801–3826 · DOI · Paper page
  10. Bentley R, Bennett JW (2003) What is an antibiotic? Revisited. Adv Appl Microbiol 52:303–331 · DOI
  11. Bentley R (2009) Different roads to discovery; Prontosil (hence sulfa drugs) and penicillin (hence b-lactams). J Ind Microbiol Biotechnol 36:775–786 · DOI
  12. Berger A, Fingerle V, Sing A (2012) Treponemen. Chapter 43. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (2012) Medizinische Mikrobiologie und Infektiologie. 7. Auflage. Springer, Berlin · doi:10.1007/978-3-642-24167-3_43
  13. Binda E, Marinelli F, Marcone GL (2014) Old and new glycopeptide antibiotics: action and resistance. Antibiotics 3:572–594 · DOI · Paper page
  14. Birch RG, Patil SS (1985) Preliminary characterization of an antibiotic produced by Xanthomonas albilineans which inhibits DNA synthesis in Escherichia coli. J Gen Microbiol 131:1069–1075
  15. Bisacchi GS (2015) Origins of the Quinolone class of antibacterials: an expanded “Discovery Story”. J Med Chem 58:4874–4882 · DOI · Paper page
  16. Bloemendal S, Kück U (2014) Cephalosporins. In: Martín JF, García-Estrada C, Zeilinger S (eds) Biosynthesis and molecular genetics of fungal secondary metabolites. Springer, New York, pp 43–64 · doi:10.1007/978-1-4939-1191-2_3
  17. Bosch F, Rosich L (2008) The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize. Pharmacology 82:171–179 · DOI · Paper page
  18. Brewer GA, Johnson MJ (1953) Activity and properties of para-aminobenzyl penicillin. Appl Microbiol 1:163–166 · doi:10.1128/am.1.4.163-166.1953
  19. Burris RH, Baumann A, Potter VR (1990) Conrad Arnold Elvehjem. Biographical memoir, Nat Acad Sc
  20. Carter GT (2009) Natural products in drug discovery. In: Stromgaard K, Krogsgaard-Larsen P, Madsen U (eds.) Textbook of drug design and discovery, 4th edn. CRC Press Boca Raton, pp 89–106
  21. Cha JY, Ishiwata A, Mobashery S (2004) A novel β-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin. J Biol Chem 279:14917–14921 · DOI
  22. Charlebois A, Jalbert LA, Harel J, Masson L, Archambault M (2012) Characterization of genes encoding for acquired bacitracin resistance. Clostridium perfringens PloS One 7(9). doi:10.1371 · doi:10.1371/journal.pone.0044449
  23. Chellat MF, Raguz L, Riedl R (2016) Antibiotikaresistenzen gezielt überwinden. Angew Chem 128:2–32 · DOI
  24. Chopra I, Roberts M (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232–260 · DOI · Paper page
  25. Cole ST (2014) Who will develop new antibacterial agents? Phil Trans R Soc B 369:20130430 · DOI
  26. Collin F, Karkare S, Maxwell A (2011) Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol 92:479–497 · DOI · Paper page
  27. Controulis J, Rebstock MC, Crooks HM (1949) Chloramphenicol (Chloromycetin). V. Synthesis. J Am Chem Soc 71:2463–2468 · doi:10.1021/ja01175a066
  28. Davies J, Wright GD (1997) Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 5:234–240 · DOI · Paper page
  29. Davies J (2006) Where have all the antibiotics gone? Can J Infect Dis Med Microbiol 17:287–290 · DOI · Paper page
  30. Di Giambattista M, Chinali G, Cocito C (1989) The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes. J Antimicrob Chemother 24:485–507 · DOI
  31. Domagk G (1935) Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Deutsch Med Wochenschrift 61:250–253 · DOI · Paper page
  32. Drews J (2000) Drug discovery: A historical perspective. Science 287:1960–1964 · DOI · Paper page
  33. Dubos RJ, Hotchkiss RD (1942) Origin, nature and property of gramicidin and tyrocidine. Trans Studies Coll Phys Phila 4(10):11–19
  34. Dubos RJ, Hotchkiss RD, Coburn AF (1942) The effect of gramicidin and tyrocidine on bacterial metabolism. J Biol Chem 146:421–426 · doi:10.1016/s0021-9258(18)44961-7
  35. Duckett S (1999) Ernest Duchesne and the concept of fungal antibiotic therapy. Lancet 11(354):2068–2071 · doi:10.1016/s0140-6736(99)03162-1
  36. Duggar BM (1948) Aureomycin; a product of the continuing search for new antibiotics. Ann N Y Acad Sci 30:177–181 · DOI · Paper page
  37. Ehrlich P, Hata S (1910) Die Experimentelle Chemotherapie der Spirillosen. Springer, Berlin · DOI
  38. Ehrlich P, Bertheim A (1912): Über das salzsaure 3.3-Diamino-4.4-dioxy-arsenobenzol und seine nächsten Verwandten. Berichte der deutschen chemischen Gesellschaft Bd 45(1):756–766 · doi:10.1002/cber.191204501110
  39. Ehrlich J, Bartz QR, Smith RM, Joslyn DA, Burkholder PR (1947) Chloromycetin, a new antibiotic from a soil actinomycete. Science 31:417 · DOI · Paper page
  40. Ehrlich J, Gottlieb D, Burkholder PR, Anderson LE, Pridham TG (1948) Streptomyces venezuelae, N. sp., The source of chloromycetin. J Bacteriol 56:467–477 · doi:10.1128/jb.56.4.467-477.1948
  41. Falkow S (1975) Infectious multiple drug resistance. Pion Ltd London United Kingdom · DOI · Paper page
  42. Ferber D (2003) Triple-threat microbe gained powers from another bug. Science 302:1488 · doi:10.1126/science.302.5650.1488
  43. Finlay AC, Hobby GL, P’an SY, Regna PP, Routien JB, Seeley DB, Shull GM, Sobin BA, Vinson IAJW, Kane JH (1950) Terramycin, a new antibiotic. Science 27:85 · doi:10.1126/science.111.2874.85.a
  44. Fleming A (1929) On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 10(3):226–236
  45. Gause GF, Brazhnikova MG (1944) Gramicidin S and its use in the treatment of infected wounds. Nature 154:703 · DOI · Paper page
  46. Gellert M, Mizuuchi K, O’Dea MH, Nash HA (1976) DNA gyrase: an enzymethat introduces superhelical turns into DNA. Proc Natl Acad Sci USA 73:3872–3876 · DOI · Paper page
  47. Gelmo P (1908) Über Sulfamide der p-Amidobenzolsulfonsäure. J prak Chem 77:369–382 · doi:10.1002/prac.19080770129
  48. Goldstein FW, Kitzis MD, Acar JF (1994) N, N-Dimethylglycylamido derivative of minocycline and 6-demethyl-6-deoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant Gram positive cocci. Antimicrob Agents Chemother 38: 2218–2220 · DOI
  49. Gosio B (1896) Ricerdre batteriologische chirmide sulle alterazioni del mais. Rivista d’Ingienne e Sanita Publica 7:825–868
  50. Gottlieb D, Bhattacharyya PK, Anderson HW, Carter HE (1948) Some properties of an antibiotic from a species of Streptomyces. J Bact 55:409–417 · doi:10.1128/jb.55.3.409-417.1948
  51. Griesgraber G, Or YS, Chu DTW, Nilius AM, Johnson PM, Flamm RK, Henry RF, Plattner JJ (1996) 3-Keto-11, 12-carbazate Derivatives of 6-O-Methylerythromycin A synthesis and in vitro activity. J Antibiot 49:465–477 · doi:10.7164/antibiotics.49.465
  52. Grohe K, Heitzer H (1987) Cycloaracylierung von Enaminen, I Synthese von 4-Chinolon-3-carbonsauren. Lieb Ann Chem 1:29–37 · doi:10.1002/jlac.198719870106
  53. Grohe K, Zeiler HJ, Metzger K (1981) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel. DE 3142854:A1
  54. Guttmann P, Ehrlich P (1891) Über die Wirkung des Methylenblau bei Malaria. Berl Klin Wochenschr 28:953–956
  55. Haensch S, Bianucci R, Signoli M et al (2010) Distinct clones of yersinia pestis caused the black death. Ed Nora J Besansky PLoS Pathogens 6(10):e1001134 · DOI · Paper page
  56. Hart GD (2001) Descriptions of blood and blood disorders before the advent of laboratory studies. Histl Rev Brit J Haem 115:719–728 · DOI
  57. Harris DA, Reagan MA, Ruger M, Wallick H, Woodruff HB (1955) Discovery and antimicrobial properties of cathomycin, a new antibiotic produced by Streptomyces spheroides n. sp. Antibiot Annu 3:909–917
  58. Hawgood BJ (2008) Alexandre Yersin (1863–1943): discoverer of the plague bacillus, explorer and agronomist. J Med Biog 16:167–172 · doi:10.1258/jmb.2007.007017
  59. Heide L (2014) New aminocoumarin antibiotics as gyrase inhibitors. Int J Med Microbiol 304:31–36 · doi:10.1016/j.ijmm.2013.08.013
  60. Herrmann J, Lukežič T, Kling A, Baumann S, Hüttel S, Petković H, Müller R (2016) Strategies for the discovery and development of new antibiotics from natural products: three case studies. Curr Top Microbiol Immunol Springer EBook · doi:10.1007/82_2016_498
  61. Hesterkamp T (2015) Antibiotics clinical development and pipeline. Curr Top Microbiol Immunol. (Springer EBook). doi:10.1007/82_2015_451 · doi:10.1007/82_2015_451
  62. Höck M (2012a) Glycopeptidantibiotika. Chapter 98. Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7 Auflage. Springer, Berlin
  63. Höck M (2012b) Makrolide. Chapter 102. Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie 7. Auflage. Springer, Berlin · doi:10.1007/978-3-642-24167-3_102
  64. Hollstein U (1973) Actinomycin. chemistry and mechanism of action. Chem Rev 6:625–652
  65. Hotchkiss RD, Dubos RJ (1940a) Fractionation of bactericidal agent from cultures of a soil bacillus. J Biol Chem 132:791–792 · doi:10.1016/s0021-9258(19)56231-7
  66. Hotchkiss RD, Dubos RJ (1940b) Chemical properties of bactericidal substances isolated from cultures of a soil bacillus. J Biol Chem 132:793–794 · doi:10.1016/s0021-9258(19)56232-9
  67. Hughes VM, Datta N (1983) Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 302:725–726 · DOI · Paper page
  68. Inglesby TV, Dennis DT, Henderson DA et al (2000) Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense JAMA 283:2281–2290
  69. Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Inf Dis 41:120–126 · DOI · Paper page
  70. Jacoby GA, Bush K (2005) Beta-lactam resistance in the 21st century. In: White DG, Alekshun MN, McDermott PF (eds) Frontiers in antimicrobial resistance. ASM Press, Washington, DC, pp 53–65 · doi:10.1128/9781555817572.ch5
  71. Jäger H (2011) Cinchona pubescens. In: Roloff, A., Weisgerber, H., Lang, U., Stimm, B. (Hrsg.): Enzyklopädie der Holzgewächse, Wiley-VCH, Weinheim, 58:1–14
  72. Johnson BA, Anker H, Meleney FL (1945) Bacitracin: A new antibiotic produced by a member of the B. subtilis group. Science 12:376–377 · DOI · Paper page
  73. Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J (2010) β-Lactam and glycopeptide antibiotics: first and last line of defense? Trends Biotechnol 28:596–604 · DOI
  74. Kahne, D Leimkuhler C, Lu W, Walsh C (2005) Glycopeptide and lipoglycopeptide antibiotics. Chem Rev 105:425–448 · DOI · Paper page
  75. Karwehl S, Stadler M (2016) Exploitation of fungal biodiversity for discovery of novel antibiotics. In: Curr Top Microbiol Immunol, in press. doi:10.1007/82_2016_496 · DOI
  76. Khosla R, Verma DD, Kapur A, Aruna RV, Khanna N (1999) Streptogramins: a new class of antibiotics. Indian J Med Sci 53:111–119
  77. Klein P, Falke D, Hahn H (2012) Ursprung der medizinischen Mikrobiologie. Chapter 2. In: Suerbaum S, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (eds) Medizinische Mikrobiologie und Infektiologie. 7. Auflage. Springer, Berlin · doi:10.1007/978-3-642-24167-3_2
  78. Kool JL (2005) Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 40(8):1166–1172 · DOI · Paper page
  79. Kretz J, Kerwat D, Schubert V, Grätz S, Pesic A, Semsary S, Cociancich S, Royer M, Süssmuth RD (2015) Total synthesis of albicidin: A lead structure from Xanthomonas albilineans for potent antibacterial gyrase inhibitors. Angew Chem Int Ed 54:1969–1973 · DOI
  80. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602 · DOI · Paper page
  81. Leclercq R (2002) Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34:482–492 · DOI · Paper page
  82. Lesher GY, Froelich EJ, Gurett MD, Baily JH, Brundage RP (1962) 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Pharm Chem 91:1063–1065 · DOI · Paper page
  83. Lešnik U, Lukežič T, Podgoršek A, Horvat J, Polak T, Šala M, Jenko B, Harmrolfs K, Ocampo-Sosa A, Martínez-Martínez L, Herron PR, Fujs S, Kosec G, Hunter IS, Müller R (2015) Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering. Angew Chem Int Ed 54:3937–3940 · DOI
  84. Levy SB (1984) Resistance to the tetracyclines. In Bryan LE (ed) Antimicrobial drug resistance. Academic Press, pp 191–240 · DOI
  85. Lewis K (2013) Platforms for antibiotic discovery. Nat Rev Drug Discovery 12:371–387 · DOI · Paper page
  86. Lewis C, Clapp HW, Grady JE (1962) In vitro and in vivo evaluation of lincomycin, a new antibiotic. Antimicrob Agents Chemother 2:570
  87. Lippi D, Conti AA (2002) Plague, policy, saints and terrorists: a historical survey. J Infect 44(4):226–228 · doi:10.1053/jinf.2002.0995
  88. Lloyd NC, Morgan HW, Nicholson BK, Ronimus RS (2005) The composition of Ehrlich’s Salvarsan: resolution of a century-old debate. Angew Chem Int Ed 44:941–944 · DOI · Paper page
  89. Majno G, Joris I (1979) Billroth and Penicillium. Rev Infect Dis 5:880–884 · doi:10.1093/clinids/1.5.880
  90. Mason DJ, Dietz A, Deboer C (1962) Lincomycin-a new antibiotic. I. Discovery and biological properties AAC 2:554–559
  91. McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powell HM, Smith JW (1952) Ilotycin, a new antibiotic. Antibiot Chemother 2:281–283
  92. Meyers BR, Kaplan K, Weinstein L (1969) Micro- biological and pharmacological behaviour of 7-chloro- lincomycin. Appl Microbiol 17:653 · doi:10.1128/am.17.5.653-657.1969
  93. Mingeot-Leclercq M-P, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance. AAC 43:727–737 · DOI · Paper page
  94. Mitscher LA, Juvarkar JV, Rosenbrook W, Andres WW, Schenck JR, Egan RS (1970) Structure of chelocardin, a novel tetracycline antibiotic. J Am Chem Soc 92:6070–6071 · DOI
  95. Morar M, Bhullar K, Hughes DW, Junop M, Wright GD (2009) Structure and mechanism of the lincosamide antibiotic adenylyltransferase LinB. Structure 17:1649–1659 · DOI
  96. Nelson ML, Park BH, Andrew JS, Georgian VA, Thomas BC, Levy SB (1993) Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines. J Med Chem 36:370–377 · DOI
  97. Nelson ML, Levy SB (1999) Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob Agents Chemother 43:1719–1724 · DOI
  98. Nelson RRS (1999) Intrinsically vancomycin-resistant Gram-positive organisms: clinical relevance and implications for infection control. J Hosp Inf 42:275–282 · DOI
  99. Neufeldt S (2003) Chronologie Chemie: Entdecker und Entdeckungen Ed. Neufeldt S. 3. Auflage Wiley VCH
  100. Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629–661 · DOI · Paper page
  101. Newton GGF, Abraham EP (1955) Cephalosporin C, a new antibiotic containing sulphur and D-aminoadipic acid. Nature 175:548 · doi:10.1038/175548a0
  102. No authors listed (1967) Gentamicin. Br Med J 21:158–159
  103. Oliva B, Gordon G, McNicholas P, Ellestad G, Chopra I (1992) Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother 36:913–919 · DOI
  104. Oppolzer W, Prelog V, Sensi P (1964) Experientia 20:336–339 · DOI
  105. Pandit N, Singla RK, Shrivastava B (2012) Current updates on oxazolidinone and its significance. Int J Med Chem. doi:10.1155/2012/159285 · doi:10.1155/2012/159285
  106. Parenti F, Beretta G, Berti M, Arioli V (1978) Teicomycins, new antibiotics from Actinoplanes teicomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties. J Antibiot 31:276–283 · doi:10.7164/antibiotics.31.276
  107. Rollo IM, Williamson J, Plackett RL (1952) Acquired resistance to penicillin and to neoarsphenamine in Spirochaeta recurrentis. Br J Pharmacol Chemother 7:33–41 · DOI
  108. Rubin RP (2007) A brief history of great discoveries in pharmacology. In celebration of the centennial anniversary of the founding of the american society of pharmacology and experimental therapeutics. Pharmacol Rev 59:289–359 · DOI
  109. Schatz A, Bugie E, Waksman S (1944) Streptomycin: A substance exhibiting antibiotic activity against gram positive and gram negative bacteria. Proc Exp Biol Med 55:66–69 · DOI · Paper page
  110. Shaw KJ, Rather PN, Hare RS, Miller GH (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57:138–163 · doi:10.1128/mr.57.1.138-163.1993 · Paper page
  111. Silver LL (2012) Chapter 2 Rational Approaches to antibacterial discovery: pre-genomic directed and phenotypic screening, 33–75. In: Dougherty TJ, Pucci MJ (eds) Antibiotic discovery and development, Springer, Berlin
  112. Smith RM, Joslyn DA, Gruhzit OM, McLean W, Penner MA, Ehrlich J (1947) Chloromycetin: biological studies · doi:10.1128/jb.55.3.425-448.1948
  113. Somma S, Gastaldo L, Corti A (1984) Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. Antimicrob Agents Chemother 26:917–923 · DOI
  114. Spoerer M, Streb J (2013) Neue deutsche Wirtschaftsgeschichte des 20. Walter de Gruyter, Jahrhunderts · doi:10.1524/9783486766561
  115. Stahlmann R, Riecke K (2004) Die Infektiologie. 5.3.14.1 Editors: Adam D, Doerr HW, Link H, Lode H (Hrsg.), Springer
  116. Sydenstricker VP (1958) The History of Pellagra. Its Recognition as a Disorder of Nutrition and Its Conquest. Am J Clin Nutr 6(4):409–414 · DOI
  117. Takeuchi T, Hikiji T, Nitta K, Yamazaki S, Abe S, Takayama H, Umezawa H (1957) Biological studies on kanamycin. J Antibiot (Tokyo) 10:107–114
  118. Thomas HW (1905) Some experiments in the treatment of trypanosomiasis. Brit Med J 1140 · doi:10.1136/bmj.1.2317.1140
  119. Tréfouël J and T, Nitti F, Bovet D (1935) Activité du p-aminophénylsulfamide sur l’infection streptococcique expérimentale de la souris et du lapin. C R Soc Biol 120(23):756
  120. Tymiak AA, Aklonis C, Bolgar MS et al (1993) Novel tetracycline glycosides active against tetracycline-resistant bacteria. J Org Chem 58:535–537 · DOI
  121. Tyndall J (1877) The optical deportment of the atmosphere in relation to the phenomena of putrefaction and infection. Philos Trans R Soc Lond 166:27–74 · DOI
  122. Waksman SA, Woodruff HB (1940) Bacteriostatic and bacteriocidal substances produced by soil actinomycetes. Proc Soc Exp Biol 45:609–614 · DOI · Paper page
  123. Waksman S, Woodruff HB (1941) Actinomyces Antibioticus, a new soil organism antagonistic to pathogenic and non-pathogenic bacteria. J Bacteriol 42:231–249 · DOI
  124. Waksman SA (1947) What is an antibiotic or an antibiotic substance? Mycologia 39:565–569 · doi:10.2307/3755196
  125. Waksman SA, Lechevalier HA, Harris DA (1949) Neomycin-production and antibiotic properties. J Clin Invest 28:934–939 · doi:10.1172/jci102182
  126. Waksman SA, Lechevalier HA (1949) Neomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms. Science 25:305–307 · doi:10.1126/science.109.2830.305
  127. Weber T, Welzel K, Pelzer S, Vente A, Wohlleben W (2003) Exploiting the genetic potential of polyketide producing streptomycetes. J Biotechnol 106:221–232 · doi:10.1016/j.jbiotec.2003.08.004
  128. Weiss HJ, Rogers J, Brand H (1973) Defective ristocetin-induced platelet aggregation in von Willebrand’s disease and its correction by factor VIII. J Clin Invest 52:2697–2707 · doi:10.1172/jci107464
  129. Williams KJ (2009) The introduction of ‘chemotherapy’ using arsphenamine—The first magic bullet. J R Soc Med 102(8):343–348 · DOI
  130. Woodward RB, Doering WE (1945) The total synthesis of quinine. J. Amer Chem Soc 67:860–874 · doi:10.1021/ja01221a051
  131. Würth I (2012) Geißler in Thüringen: Die Entstehung einer spätmittelalterlichen Häresie (Hallische Beiträge zur Geschichte des Mittelalters und der Frühen Neuzeit, Band 10 · doi:10.1524/9783050057910
  132. Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban DJ (2002) The ketolides: a critical review. Drugs 62:1771–1804 · DOI · Paper page
  133. Zimdahl RL (2015) Six chemicals that changed agriculture. 1st edn. Academic Press Elsevier · doi:10.1016/b978-0-12-800561-3.00001-8

Cited by

See all 287

Metadata

Authors
Mohr, K. I.
Venue
Current Topics in Microbiology and Immunology
Publisher
Springer International Publishing
Published
2016
Volume
398
Pages
237-272
ISSN
  • 0070-217X (ISSN-L)
  • 2196-9965
DOI
10.1007/82_2016_499
OpenAlex
W2530012524
Cited by
287
References
4
FWCI
43.10
Type
book chapter
Language
en
Open access
closed
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: History of Antibiotics Research. https://app.cochat.ai/papers/10.1007/82_2016_499
The paper
Mohr, K. I. (2016). History of Antibiotics Research. Current Topics in Microbiology and Immunology. https://doi.org/10.1007/82_2016_499

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.